Corporate ActionJun 26, 2026, 04:21 PM
Creative Medical Technology Holdings to Offer Stock & Warrants for $5.34M
AI Summary
Creative Medical Technology Holdings, Inc. announced a public offering of up to 3,045,685 shares of common stock and 6,091,371 Public Warrants, along with up to 3,045,685 pre-funded warrants. The offering, priced at an assumed $1.97 per share and accompanying Public Warrants, is expected to generate approximately $5.34 million in net proceeds. The company plans to use these funds to advance its clinical trials for chronic lower back pain and Type I Diabetes, further develop its iPScelz™ program, and for general corporate purposes. The offering is being conducted on a "best efforts" basis through Roth Capital Partners, LLC.
Key Highlights
- Public offering of up to 3,045,685 common shares and 6,091,371 Public Warrants.
- Includes up to 3,045,685 pre-funded warrants.
- Assumed public offering price of $1.97 per share and accompanying Public Warrants.
- Estimated net proceeds of approximately $5.34 million.
- Proceeds to fund clinical trials for back pain and Type I Diabetes.
- Funds also for iPScelz™ program and general corporate purposes.
- Roth Capital Partners, LLC is the exclusive placement agent.
- Offering is on a "best efforts" basis with no minimum.
Price Impact
More from CELZ